Copyright
©The Author(s) 2022.
World J Clin Cases. Jun 6, 2022; 10(16): 5387-5393
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5387
Published online Jun 6, 2022. doi: 10.12998/wjcc.v10.i16.5387
Table 3 Differences between idiopathic membranous nephropathy and minimal change disease in children
IMN | MCD | ||
General features | Sex | Male | Male |
Age | Adolescence | Preschool age | |
Clinical manifestations | Nephrotic syndrome | Common | Common |
Leukocyturia | Some | Rare | |
Hematuria | Some | Rare | |
Hypertension | Some | Rare | |
Renal failure | Some | Rare | |
Laboratory tests | Anti-PLA2R, antibody | Elevated | Normal |
Anti-THSD7A, antibody | Elevated | Normal | |
Treatment strategy | Prednisone | Mostly resistance | Mostly sensitive |
Immunosuppressant | Tacrolimus, cyclophosphamide, mycophenolate mofetil | Rare | |
Biological agent | Rituximab | Rare |
- Citation: Cui KH, Zhang H, Tao YH. Idiopathic membranous nephropathy in children: A case report. World J Clin Cases 2022; 10(16): 5387-5393
- URL: https://www.wjgnet.com/2307-8960/full/v10/i16/5387.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i16.5387